CM10 Stock Overview
An investment company, operates in the cannabis sector in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Waverunner Capital Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$0.02 |
| 52 Week Low | US$0.0001 |
| Beta | 3.33 |
| 11 Month Change | 0% |
| 3 Month Change | 400.00% |
| 1 Year Change | -97.50% |
| 33 Year Change | -99.70% |
| 5 Year Change | -99.95% |
| Change since IPO | -99.97% |
Recent News & Updates
Recent updates
Shareholder Returns
| CM10 | DE Capital Markets | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 4.5% |
| 1Y | -97.5% | 29.0% | 13.4% |
Return vs Industry: CM10 underperformed the German Capital Markets industry which returned 28.7% over the past year.
Return vs Market: CM10 underperformed the German Market which returned 12.6% over the past year.
Price Volatility
| CM10 volatility | |
|---|---|
| CM10 Average Weekly Movement | 914.7% |
| Capital Markets Industry Average Movement | 4.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: CM10's share price has been volatile over the past 3 months.
Volatility Over Time: CM10's weekly volatility has increased from 533% to 915% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | n/a | Karl Kottmeier | www.waverunnercapital.com |
Waverunner Capital Inc., an investment company, operates in the cannabis sector in Canada. It also holds investments in renewable energy in the wind and solar sector; a plant-based wellness company; and consumer-targeted biotechnology venture. The company was formerly known as Chemistree Technology Inc. and changed its name to Waverunner Capital Inc. in June 2024.
Waverunner Capital Inc. Fundamentals Summary
| CM10 fundamental statistics | |
|---|---|
| Market cap | €326.60k |
| Earnings (TTM) | -€2.76m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.1x
P/E RatioIs CM10 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CM10 income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$4.16m |
| Earnings | -CA$4.16m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.056 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -162.6% |
How did CM10 perform over the long term?
See historical performance and comparison